Immunisation menuAustralian Immunisation Handbook, 8th Edition 9/2003

The new immunisation schedule (Table 1.7.1) incorporates all vaccines recommended as 'best practice'. Immunisation providers are responsible for advising patients and parents/caregivers of available vaccine choices at the time of consultation, including those provided free under the National Immunisation Program. Information about the National Immunisation Program can be obtained from your State or Territory health authority.

 

Table 1.7.1: Australian Standard Vaccination Schedule .. 1 page pdf

AGE

VACCINE

B i r t h

Hepatitis B1

 

 

 

 

 

 

 

 

2 months

Hepatitis B2,3

DTPa

Hib1,2

IPV

 

 

7vPCV

 

 

4 months

Hepatitis B2,3

DTPa

Hib1,2

IPV

 

 

7vPCV

 

 

6 months

Hepatitis B2

DTPa

Hib1

IPV

 

 

7vPCV

 

 

12 months

Hepatitis B3

 

Hib1,2

 

MMR

 

 

MenCCV

 

18 months

 

 

 

 

 

VZV

23vPPV1

 

 

2 years

 

 

 

 

 

 

 

 

 

4 years

 

DTPa

 

IPV

MMR

 

 

 

 

10 13 years

Hepatitis B4

 

 

 

 

VZV1

 

 

 

15 17 years

 

dTpa

 

 

 

 

 

 

 

50 years & over

 

dT

 

 

 

 

23vPPV2

 

Influenza(annual)2

65 years & over

 

 

 

 

 

 

23vPPV

 

Influenza(annual)

 

Schedule key

Hepatitis B1

Monovalent hepatitis B vaccine.

Hepatitis B2

Hepatitis B vaccine given as either monovalent vaccine or in combination with DTPa, 3 doses at 2, 4 and 6 months, in addition to the birth dose for a total of 4 doses

Hepatitis B3

Hepatitis B vaccine in combination with Hib (PRP-OMP), 3 doses at 2, 4 and 12 months, in addition to the birth dose for a total of 4 doses.

Hepatitis B4

Hepatitis B vaccine for 10 to 13 year olds who have not received a primary course

Hib1

PRP-T, HbOC (non-Indigenous children).

Hib2

PRP-OMP (all children).

23vPPV1

Pneumococcal polysaccharide vaccine (Aboriginal and Torres Strait Islander children only); this dose can be given between 18 months and 2 years of age (refer to State/Territory Public Health Units for recommended age for administration).

23vPPV2 & Influenza2

National Indigenous Pneumococcal and Influenza Immunisation Program.

VZV1

Vaccination only for children with a negative history of varicella disease or vaccination.

 

Notes: Aboriginal and Torres Strait Islander children receive 3 doses of PRP-OMP Hib vaccine.

Non-Indigenous children can receive 3 doses of PRP-OMP Hib vaccine or 4 doses of either PRP-T or HbOC Hib vaccine. (Mixing Hib schedules is not recommended. Infants starting with PRP-OMP should continue with PRP-OMP.)

Adolescent hepatitis B and VZV are not required if a primary vaccination course has been given in early childhood.

Access to free pneumococcal conjugate vaccine is provided to the following groups; all Aboriginal and Torres Strait Islander children aged up to 2 years, Aboriginal children in central Australia aged up to 5 years, non-Indigenous children in central Australia aged up to 2 years, and all children under 5 years with medical risk factors that predispose them to high rates or high severity of pneumococcal infection.

IPV is preferred to OPV, subject to the availability of IPV-combination vaccines, but both IPV and OPV are acceptable for use in the ASVS

Vaccine Key

Hepatitis B

Hepatitis B vaccine

DTPa

Diphtheria-tetanus-acellular pertussis infant/child formulation

dTpa

Adult/adolescent formulation diphtheria-tetanus- acellular pertussis vaccine

Hib

Haemophilus influenzae type b (Hib) vaccine PRP-OMP, PRP-T, HbOC (as monovalent or in combination)

IPV

Inactivated poliomyelitis vaccine (in combination)

MMR

Measles-mumps-rubella vaccine

VZV

Varicella-zoster vaccine

7vPCV

7-valent pneumococcal conjugate vaccine

23vPPV

23-valent pneumococcal polysaccharide vaccine

MenCCV

Meningococcal C conjugate vaccine

Influenza

Influenza vaccine

dT

Adult diphtheria-tetanus vaccine.